Synthetic corkscrew peptide kills antibiotic-resistant Gram-negativ... ( HOUSTON An engineered peptide provi...)

Synthetic corkscrew peptide kills antibiotic-resistant Gram-negative bacteria

Date:1/24/2013

HOUSTON An engineered peptide provides a new prototype for killing an entire category of resistant bacteria by shredding and dissolving their double-layered membranes, which are thought to protect those microbes from antibiotics.

The synthetic peptide was effective in lab experiments against antibiotic-resistant Gram-negative bacteria, which cause a variety of difficult-to-treat, potentially lethal infections such as pneumonia and sepsis.

The team led by scientists at The University of Texas MD Anderson Cancer Center reported its findings online in advance of print this week at the Proceedings of the National Academy of Science.

"The antibiotic pipeline against multidrug-resistant Gram-negative problem pathogens is a major unmet need in contemporary medicine; as such, our new antimicrobial agent holds immediate promise," said co-senior author Wadih Arap, M.D., professor in MD Anderson's Department of Genitourinary Medical Oncology and the David H. Koch Center.

Arap, Renata Pasqualini, Ph.D., also a co-senior author, professor in genitourinary medical oncology and the Koch center, and colleagues have previously constructed peptide combinations that are in development against cancer and white fat cells.

"The prototype introduced here as an antibiotic candidate has a unique mechanism of action and translational applications readily identified," Pasqualini said.

Gram-negative bacteria that are highly resistant to existing treatments include E. coli, Acinetobacter baumanii, Pseudomonas aeruginosa, and kebsiella pneumonia. These infections are often present in health care settings and most threatening to people with weakened immune systems.

The spiral peptide called KLAKLAKKLAKLAK acts against bacteria by puncturing their lipid bilayer membranes and has only low toxicity toward mammalian cells. These antimicrobial peptides, however, are subject to routine destruction by host enzymes
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Biosynthetic grape-derived compound prevents progression of Alzheimers disease in mice
2. Stimulant marketed as natural in sports supplement actually of synthetic origin
3. Synthetic stimulants called bath salts act in the brain like cocaine
4. Scientists explore new class of synthetic vaccines
5. Boston University researchers expand synthetic biologys toolkit
6. Synthetic Skin Heals Itself With a Touch, Study Shows
7. Researchers build synthetic membrane channels out of DNA
8. Probiotic Action Issues a Response to an Article on Medical News Today About Synthetic Skin Research
9. Synthetic Pot Sending Thousands of Young People to ER: Report
10. Strange behavior: New study exposes living cells to synthetic protein
11. Combination peptide therapies might offer more effective, less toxic cancer treatment

Post Your Comments:

(Date:5/22/2013)... Margate City, NJ (PRWEB) May 22, 2013 ... from solved. In some states, up to twenty-seven percent ... half of all bankruptcies of private citizens in the U.S. ... medical care also affects prescription drugs, meaning that many patients ... doctor, or even get them filled at all. That's ...

(Date:5/22/2013)... Beginning Aug. 22, teens are invited ... Spirit of Innovation Challenge . The annual program ... and open to students ages 13 - 18 from ... Challenge celebrates the life and entrepreneurial spirit of astronaut ... The program challenges teens to work in teams of ...

(Date:5/22/2013)... May 22, 2013 The 2013 release of ... is the largest change to hit the field of mental ... is will help prepare for the release with a Webinar ... been trained knowing no other diagnostic scheme besides the now ... manual will be released worldwide. In honor of this event, ...

(Date:5/22/2013)... May 22, 2013 Abadir Associates, a ... treatments for optimal results, is offering a new technique ... neck. The practice has successfully treated multiple patients ... “Basically, this approach is for women who want to ... dermatologist Dr. Michelle Abadir of Abadir Associates. ...

(Date:5/22/2013)... May 22 2013 - Research presented today shows ... in rats similar to those produced by drugs ... presented by addiction expert Francesco Leri, Associate Professor ... University of Guelph, suggest food addiction could explain, ... These results were presented at the 2013 ...

Breaking Medicine News(10 mins):Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2 Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2 Health News:What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 2 Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2 Health News:Addiction to unhealthy foods could help explain the global obesity epidemic 2

[0] Lyrica Discount Cards Now Available From MedicationDiscountCard.com [0] Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date [0] What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 [0] Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative [0] Addiction to unhealthy foods could help explain the global obesity epidemic

... the standard treatment regimen for hepatitis C significantly increases the ... to a research report published Monday in the online edition ... team, led by Paul Kwo, M.D., of Indiana University School ... treatment,s effectiveness when given for 48 weeks in one treatment ...

... by researchers at the Bradley Hasbro Children,s Research Center ... some of the well-documented ethnic disparities in pediatric asthma. ... children in the study tended to think they were ... tests actually revealed normal lung function. According to ...

... Adding a direct acting anti-viral drug to the standard ... in the most difficult to treat patients, according to a ... journal The Lancet . The research team, led ... reported that adding the drug nearly doubled the treatment,s effectiveness ...

... The University of Colorado College of Nursing has been ... Health and Human Services, Health Resources and Services Administration ... to provide leadership for high quality healthcare in rural ... a competitively awarded grant to i-LEAD, Innovation in Leadership ...

... Reporter , FRIDAY, Aug. 6 (HealthDay News) -- "Locally grown" ... It,s a concept that has made many Americans scan their ... been raised nearby. But are locally grown foods necessarily ... grown locally will be much healthier; others, not so much. ...

... 2010 SIRIUS XM Radio (NASDAQ: SIRI) today announced ... Doctor Radio Reports: Understanding Autism - Looking for Answers, ... Perri Peltz on which a panel of world-class doctors, ... the latest research and treatment options for autism and ...

Cached Medicine News:Health News:New antiviral drug shows promise for dramatic improvement in hepatitis C treatment 2 Health News:New antiviral drug shows promise for dramatic improvement in hepatitis C treatment 3 Health News:Latino children with asthma less accurate in determining their lung function 2 Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 2 Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 3 Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 2 Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 3 Health News:'Locally Grown' May Mean Healthier, But Not Always 2 Health News:'Locally Grown' May Mean Healthier, But Not Always 3 Health News:Sirius XM to broadcast 'Doctor Radio Reports: Understanding Autism -- Looking for Answers' 2

New antiviral drug shows promise for dramatic improvement in hepatitis C treatment Latino children with asthma less accurate in determining their lung function New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment College of Nursing awarded grant for nursing leadership in rural and underserved areas 'Locally Grown' May Mean Healthier, But Not Always Sirius XM to broadcast 'Doctor Radio Reports: Understanding Autism -- Looking for Answers'

(Date:5/22/2013)... 22, 2013 Upsher-Smith Laboratories, Inc. ... its global Phase III clinical trial for ... for the management of epilepsy in adults, ... is specifically engineered to provide convenient once-daily ... levels observed with currently available treatment options. ...

(Date:5/22/2013)... 22, 2013 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... of the company at the following conferences. , ... date: Wednesday May 29, 2013 , Presentation time: 12:00 ... Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of these ...

(Date:5/22/2013)... REHOVOT, Israel , May 22, 2013 ... a leading developer and provider of microRNA-based molecular diagnostics, ... President and Chief Executive Officer of Rosetta Genomics, will ... Conference taking place from June 3-6, 2013 in New ... Tuesday, June 4 th at 2:00 p.m. Eastern ...

Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4 Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3

[0] Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures [0] Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences [0] Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

... NEW YORK, Nov. 8, 2010 Reportlinker.com ... is available in its catalogue: ... Technology platforms, key players, and early pipeline ... Therapeutic vaccines promise a ...

... Nov. 8, 2010 Reportlinker.com announces that ... in its catalogue: Opportunities ... growth in key regions and therapeutic areas ... The flurry of recent industry acquisitions ...

Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas

... The Summit SI Spinal Fixation ... for rigid posterior fixation of ... spine. The simplicity and versatility ... optimize the construct based on ...

OctaFix is designed specifically to provide stability and fixation where it is most needed....

...

Medicine Products:

Summit SI Spinal Fixation System Octafix Adson Cranial Rongeur Bateman Rongeur